Antibodies to chlamydial lipopolysaccharides in unstable angina pectoris

American Journal of Cardiology

Volumn 87, Issue 10, 2001, Pages 1150-1153

  Kähler, Jan ^a   Gerth, Sabine ^a   Schäfer, Peter ^b   Boersma, Eric ^f   Köster, Ralf ^a   Terres, Wolfram ^d   Simoons, Maarten L ^f   Berger, Joachim ^c   Meinertz, Thomas ^a   Hamm, Christian W ^e  

^a Department of Cardiology ^*  (Germany)

^b Institut fur Medizinische Mikrobiologie und Immunologie   (Germany)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d ALLGEMEINES KRANKENHAUS CELLE   (Germany)

^e KERCKHOFF HEART CENTER   (Germany)

^f ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; BACTERIUM LIPOPOLYSACCHARIDE; C REACTIVE PROTEIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PLACEBO; TROPONIN T;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; CHLAMYDOPHILA PNEUMONIAE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HEART INFARCTION; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RISK FACTOR; TREATMENT OUTCOME; UNSTABLE ANGINA PECTORIS;

AGED; ANGINA, UNSTABLE; ANTIBODIES, BACTERIAL; C-REACTIVE PROTEIN; CHLAMYDIA; CHLAMYDOPHILA PNEUMONIAE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LIPOPOLYSACCHARIDES; MALE; MIDDLE AGED; PROGNOSIS; SURVIVAL RATE; TROPONIN T;

EID: 17144438831     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(01)01484-9     Document Type: Article

References (22)

1. Saikku P., Mattila K., Nieminen M.S., Huttunen J.K., Leinonen M., Ekman M.R., Makela P.H., Valtonen V. Serological evidence of an association of a novel chlamydia twar with chronic coronary heart disease and acute myocardial infarction. Lancet. 2:1988;983-986.
2. Saikku P., Leinonen M., Tenkanen L., Linnanmaeki E., Ekman M.R., Manninen V., Maenttaeri M., Frick M.H., Huttunen J.K. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann Int Med. 116:1992;273-278.
3. Jackson L.A., Campbell L.A., Schmidt R.A., Kuo C.C., Cappuccio A.L., Lee M.J., Grayston J.T. Specificity of detection of Chlamydia pneumoniae in cardiovascular atheroma evaluation of the innocent bystander hypothesis . Am J Pathol. 150:1997;1785-1790.
4. Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina the CAPTURE study . Lancet. 349:1997;1429-1435.
5. Brade L., Brunnemann H., Ernst M., Fu Y., Kosma P., Näher H., Persson K., Brade H. Occurrence of antibodies against chlamydial lipopolysaccharide in human sera as measured by ELISA using an artificial glycoconjugate antigen. FEMS Immunol Med Microbiol. 8:1994;27-43.
6. Hamm C.W., Ravkilde J., Gerhardt W., Jorgensen P., Peheim E., Ljungdahl L., Goldmann B., Katus H.A. The prognostic value of serum troponin T in unstable angina. N Engl J Med. 327:1992;146-150.
7. Katus H.A., Looser S., Hallermayer K., Remppis A., Scheffold T., Borgya A., Essig U., Geuss U. Development and in vitro characterization of a new immunoasay of cardiac troponin T. Clin Chem. 38:1992;386-393.
8. Kleinbaum D.G. Applied Regression Analysis and Other Multivariate Methods. 1998;Duxbury Press, Pacific Grove, CA.
9. Ridker P.M., Cushman M., Stampfer M.J., Tracy R.P., Hennekens C.H. Inflammation, aspirin, and the risk of cardiovascular-disease in apparently healthy men. N Engl J Med. 336:1997;973-979.
10. Mendall M.A., Patel P., Ballam L., Strachan D., Northfield T.C. C reactive protein and its relation to cardiovascular risk factors a population based cross sectional study . BMJ. 312:1996;1061-1065.
11. Katus H.A., Remppis A., Neumann F.J., Scheffold T., Diederich K.W., Vinar G., Noe A., Matern G., Kuebler W. Diagnostic efficiency of troponin T measurements in acute myocardial infarction. Circulation. 83:1991;902-912.
12. Hamm C.W., Goldmann B.U., Heeschen C., Kreymann G., Berger J., Meinertz T. Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I. N Engl J Med. 337:1997;1648-1653.
13. Carlsson J., Miketic S., Mueller K.H., Brom J., Ross R., von Essen R., Tebbe U. Previous cytomegalovirus or Chlamydia pneumoniae infection and risk of restenosis after percutaneous transluminal coronary angioplasty (lett). Lancet. 350:1997;1225.
14. Tiran A., Tio R.A., Ossewaarde J.M., Tiran B., Den Hijer P., The T.H., Wilders-Truschnig M.M. Coronary angioplasty induces rise in Chlamydia pneumoniae-specific antibodies. J Clin Microbiol. 37:1999;1013-1017.
15. Mazzoli S., Tofani N., Fantini A., Semplici F., Bandini F., Salvi A., Vergassola R. Chlamydia pneumoniae antibody response in patients with acute myocardial infarction and their follow-up. Am Heart J. 135:1998;15-20.
16. Brade H., Brade L., Nano F.E. Chemical and serological investigations on the genus-specific lipopolysaccharide epitope of Chlamydia. Proc Natl Acad Sci USA. 84:1987;508-512.
17. Verkooyen R.P., Van Lent N.A., Joulandan S.A.M., Snijder R.J., Van den Bosch J.M., Van Helden H.P., Verbrugh H.A. Diagnosis of Chlamydia pneumoniae infection in patients with chronic obstructive pulmonary disease by microimmunofluorescence and ELISA. J Med Microbiol. 46:1997;959-964.
18. Verkooyen R.P., Willemse D., Hiep van Casteren S.C., Joulandan S.A.M., Snijder R.J., Van den Bosch J.M., Van Helden H.P., Peeters M.F., Verbrugh H.A. Evaluation of PCR, culture, and serology for diagnosis of Chlamydia pneumoniae respiratory infections. J Med Microbiol. 36:1998;2301-2307.
19. Mayr M., Metzler B., Kiechl S., Willeit J., Schett G., Xu Q., Wick G. Endothelial cytotoxicity mediated by serum antibodies to heat shock proteins of Escherichia coli and Chlamydia pneumoniae. Circulation. 99:1999;1560-1566.
20. Davidson M., Kuo C.C., Middaugh J.P., Campbell L.A., Wang S.P., Newman W.Pr., Finley J.C., Grayston J.T. Confirmed previous infection with Chlamydia pneumoniae (TWAR) and its presence in early coronary atherosclerosis. Circulation. 98:1998;628-633.
21. Toss H., Gnarpe J., Gnarpe H., Siegbahn A., Lindahl B., Wallentin L. Increased fibrinogen levels are associated with persistent Chlamydia pneumoniae infection in unstable coronary artery disease. Eur Heart J. 19:1998;570-577.
22. Anderson J.L., Carlquist J.F., Muhlestein J.B., Horne B.D., Elmer S.P. Evaluation of C-reactive protein, an inflammatory marker, and infectious serology as risk factors for coronary artery disease and myocardial infarction. J Am Coll Cardiol. 32:1998;35-41.